MHC-II neoantigens shape tumour immunity and response to immunotherapy-Reference-Cited by-同舟云学术

MHC-II neoantigens shape tumour immunity and response to immunotherapy

Published:2019-10-23 Issue:7780 Volume:574 Page:696-701
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Alspach Elise,Lussier Danielle M.,Miceli Alexander P.,Kizhvatov Ilya,DuPage Michel,Luoma Adrienne M.,Meng Wei,Lichti Cheryl F.,Esaulova Ekaterina,Vomund Anthony N.,Runci Daniele,Ward Jeffrey P.,Gubin Matthew M.,Medrano Ruan F. V.,Arthur Cora D.,White J. Michael,Sheehan Kathleen C. F.,Chen Alex,Wucherpfennig Kai W.,Jacks Tyler,Unanue Emil R.,Artyomov Maxim N.,Schreiber Robert D.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41586-019-1671-8.pdf

Reference43 articles.

1. Schreiber, R. D., Old, L. J. & Smyth, M. J. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science 331, 1565–1570 (2011).

2. Larkin, J. et al. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N. Engl. J. Med. 373, 23–34 (2015).

3. Motzer, R. J. et al. Nivolumab versus everolimus in advanced renal-cell carcinoma. N. Engl. J. Med. 373, 1803–1813 (2015).

4. Borghaei, H. et al. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N. Engl. J. Med. 373, 1627–1639 (2015).

5. Lennerz, V. et al. The response of autologous T cells to a human melanoma is dominated by mutated neoantigens. Proc. Natl Acad. Sci. USA 102, 16013–16018 (2005).

Cited by 594 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro-irradiated cancer vaccine enhances anti-tumor efficacy of radiotherapy and PD-L1 blockade in a syngeneic murine breast cancer model;Radiotherapy and Oncology;2024-11

2. MDM2 inhibitors in cancer immunotherapy: Current status and perspective;Genes & Diseases;2024-11

3. Complete Cure of Inoperable Stage IV Locally Advanced Hypopharyngeal Squamous Cell Carcinoma by an Innovative Combination Cancer Immunotherapy Consisting of Radiation, Immune Checkpoint Inhibitors, and Dendritic Cell Vaccine;Cureus;2024-09-14

4. Causal Effect of Immunocytes, Plasma Metabolites, and Hepatocellular Carcinoma: A Bidirectional Two-Sample Mendelian Randomization Study and Mediation Analysis in East Asian Populations;Genes;2024-09-09

5. Neoantigen-specific T cell help outperforms non-specific help in multi-antigen DNA vaccination against cancer;Molecular Therapy: Oncology;2024-09